Asembia expands collaboration with Pfizer oncology Ruby Khatun Khatun23 April 2018 9:45 AM ISTAsembia members can now gain expanded access to Pfizer Oncology defined distribution oncology products for qualified hospital and health system...
Biogen boosts investment in neurology with 1 billion dollar Ionis deal Ruby Khatun Khatun23 April 2018 9:30 AM ISTBiogen Inc struck a $1 billion neurology drug development deal with Ionis Pharmaceuticals, expanding a partnership that developed the company’s...
HC Rescues Lupin on Price cap on powdered form of asthma drug Ruby Khatun Khatun22 April 2018 11:58 AM ISTNew Delhi: The Delhi High Court directed the Centre not to take any coercive measure against Indian pharma major Lupin Ltd which has challenged a...
Glenmark Pharma gets USFDA nod for scalp and skin treatment drug Ruby Khatun Khatun22 April 2018 10:30 AM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for a generic version of Temovate Topical Solution used...
USFDA completes Ghaziabad plant inspection, no observations issued: Unichem Ruby Khatun Khatun22 April 2018 10:15 AM ISTNew Delhi: Drug firm Unichem Laboratories said it has not received any observations from the US health regulator after completion of inspection of its...
FDA approves Rigel Pharmaceuticals drug for rare bleeding disorder Ruby Khatun Khatun22 April 2018 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) on Tuesday approved Rigel Pharmaceuticals Inc’s treatment for a rare bleeding disorder.Rigel’s Tavalisse...
Experts query case for GlaxoSmithKline's new 3-in-1 lung drug Ruby Khatun Khatun22 April 2018 9:45 AM ISTLONDON: Two medical experts have urged caution in using a new three-in-one inhaler for chronic lung disease from GlaxoSmithKline, which the company...
344 FDC Drugs Issue: DGHS extends timeline for response Ruby Khatun Khatun22 April 2018 9:30 AM ISTNew Delhi: Through a recent notification, Directorate General of Health Services taking in of the directions of the Hon'ble Supreme Court of India in...
Abbott sticks to earlier forecasts, disappoints investors Ruby Khatun Khatun22 April 2018 9:30 AM ISTAbbott Laboratories' just beat expectations for first-quarter profits and revenue but stuck to a full-year profit forecast some investors had expected...
Cognizant completes acquisition of Bolder Healthcare Solutions Ruby Khatun Khatun21 April 2018 11:00 AM ISTNew Delhi: IT firm Cognizant said it has completed the acquisition of Bolder Healthcare Solutions, a provider of revenue cycle management (RCM)...
P&G to acquire 51.8 percent stake in Merck in India for Rs 1,290 crore Ruby Khatun Khatun21 April 2018 10:30 AM ISTNew Delhi: Procter & Gamble (P&G) will acquire 51.80 percent stake for Rs 1,289.88 crore in India listed drug firm Merck Ltd as part of a...
Top Indian Pharma formulators eyeing OTC market: Report Ruby Khatun Khatun21 April 2018 10:30 AM ISTMumbai: Indian pharmaceutical formulators are expected to continue to make investments in consumer healthcare, wellness products, and traditional OTC...
